MN Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$418K Buy
834
+201
+32% +$96.5K 0.18% 86
2026
Q1
$311K Buy
633
+21
+3% +$11.4K 0.15% 98
2025
Q4
$355K Buy
612
+12
+2% +$6.79K 0.18% 81
2025
Q3
$291K Sell
600
-58
-9% -$27K 0.16% 90
2025
Q2
$267K Buy
658
+64
+11% +$26.8K 0.16% 95
2025
Q1
$296K Buy
594
+154
+35% +$83.4K 0.17% 87
2024
Q4
$229K Buy
440
+26
+6% +$14.3K 0.13% 91
2024
Q3
$256K Sell
414
-5
-1% -$2.96K 0.15% 84
2024
Q2
$232K Buy
419
+11
+3% +$6.3K 0.13% 92
2024
Q1
$238K Sell
408
-14
-3% -$7.86K 0.15% 82
2023
Q4
$224K Buy
+422
New +$204K 0.15% 82

Other funds holding TMO

MN Wealth Advisors's TMO Position: Q2 2026 in Review

MN Wealth Advisors increased its Thermo Fisher Scientific (TMO) stake by 32% in Q2 2026, buying an estimated $96.5K and bringing the position to 834 shares worth $418K. The position accounts for 0.18% of the portfolio, ranked #86.

MN Wealth Advisors first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • MN Wealth Advisors held 834 shares of Thermo Fisher Scientific worth $418K as of Q2 2026.
  • MN Wealth Advisors bought 201 Thermo Fisher Scientific shares in Q2 2026, an estimated $96.5K.
  • Thermo Fisher Scientific made up 0.18% of MN Wealth Advisors's portfolio in Q2 2026, its #86 holding.
  • MN Wealth Advisors first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on MN Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.